A sterile preservative-free solution with identical composition as the drug product, but without the protein.
KPL-404-C221
Phase 2 small_molecule active
Quick answer
A sterile preservative-free solution with identical composition as the drug product, but without the protein. for Sjögren’s Disease is a Phase 2 program (small_molecule) at Kiniksa Pharmaceuticals International, plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kiniksa Pharmaceuticals International, plc
- Indication
- Sjögren’s Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active